Year: 2019

Arcutis Announces Top Line Results for Phase 2 Proof-of-Concept Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Atopic Dermatitis

- Consistent evidence of symptomatic improvement across endpoints and favorable tolerability - Higher dose demonstrated trend towards significance on primary...

Adial Pharmaceuticals Receives Notice of Allowance of Additional Patent for the Treatment of Alcohol Use Disorder with AD04 in Patients Identified Using a Molecular Genetic Biomarker

CHARLOTTESVILLE, VA / ACCESSWIRE / December 16, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...

Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium to Accelerate Development of Donor-Independent Platelet Production

Company also bolsters Scientific Advisory Board with Additions of Uma Lakshmipathy, Ph.D. and Teresa Foy, Ph.D. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Platelet BioGenesis,...

error: Content is protected !!